MedTrace Logo

Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes

NCT00796926 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-10-07

Study results available
· View outcomes & findings →

Summary

Systane Ultra is at least as efficacious and safe as Refresh Tears in Asian people with Dry Eyes

Conditions

  • Xerophthalmia
  • Blepharitis

Interventions

DRUG

Systane Ultra eyedrops

Four times a day

DRUG

Refresh eye drops

Four times a day

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Louis Tong

    lead OTHER_GOV

Principal Investigators

  • Louis Tong, FRCS, MD · Singapore National Eye Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796926 on ClinicalTrials.gov